RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: IgA glomerulonephritis
Accession: DOID:2986
browse the term
Definition: A glomerulonephritis characterized by build up of IgA antibody in the glomerulus. (DO)
Synonyms: exact_synonym: Berger disease; Berger's IgA or IgG nephropathy; Berger's disease; Bergers Disease; Glomerulonephritides, IGA; IGA Nephropathy; IGA Type Nephritis; IGAN; IGAN1; IGAN2; IGAN3; IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; Iga Nephropathy 1; focal glomerulonephritis; immunoglobulin A nephropathy; primary IgA nephropathy; segmental glomerulonephritis; susceptibility to IgA nephropathy-3
related_synonym: Iga nephropathy, susceptibility to; susceptibility to progression to renal failure in IgA nephropathy
primary_id: MESH:D005922
alt_id: MIM:161950 ; MIM:613944 ; MIM:616818
xref: EFO:0004194 ; GARD:863 ; MIM:PS161950 ; NCI:C34643 ; NCI:C35280
For additional species annotation, visit the
Alliance of Genome Resources .
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Ace
angiotensin I converting enzyme
disease_progression
ISO
DNA:polymorphism:intron: CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Susceptibility to progression to renal failure in IgA nephropathy
CTD ClinVar RGD
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:15118671 PMID:12220450 More...
RGD:1331525 , RGD:7257515
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
disease_progression
ISO
DNA:polymorphism: :
RGD
PMID:12484505
RGD:7241283
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
G
Adam10
ADAM metallopeptidase domain 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32715474
NCBI chr 8:71,346,008...71,477,889
Ensembl chr 8:71,345,837...71,477,889
G
Add1
adducin 1
disease_progression
ISO
DNA:polymorphism:cds:rs4961(human)
RGD
PMID:19838659
RGD:7174725
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
G
Add2
adducin 2
disease_progression
ISO
DNA:polymorphism:cds: rs4984(human)
RGD
PMID:19838659
RGD:7174725
NCBI chr 4:118,444,594...118,538,505
Ensembl chr 4:118,497,416...118,538,505
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9259580
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
ISO
protein:increased expression:kidney tubule
RGD
PMID:15930094
RGD:6903851
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Agtr2
angiotensin II receptor, type 2
disease_progression
ISO
DNA:polymorphism: :1818A>T (human) protein:increased expression:kidney tubule
RGD
PMID:19194560 PMID:15930094
RGD:6903844 , RGD:6903851
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Aurkb
aurora kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
B4galt1
beta-1,4-galactosyltransferase 1
ISS
OMIM:161950 | OMIM:616818
MouseDO
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
G
C1qa
complement C1q A chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8840296 PMID:25133636
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
G
C1qb
complement C1q B chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
G
C2
complement C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
G
C3
complement C3
ISO
mRNA,protein:increased expression, increased activity:kidney
RGD
PMID:11287758
RGD:7175543
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Card9
caspase recruitment domain family, member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25305756
NCBI chr 3:9,171,814...9,180,310
Ensembl chr 3:9,171,815...9,180,237
G
Ccl2
C-C motif chemokine ligand 2
IEP
protein:increased expression:kidney
RGD
PMID:18433541
RGD:2307041
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
disease_progression
ISO
RGD
PMID:23192593
RGD:7483632
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccr6
C-C motif chemokine receptor 6
disease_progression
ISO
RGD
PMID:23192593
RGD:7483632
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
G
Cd14
CD14 molecule
disease_progression
ISO
DNA:polymorphism:promoter:c. -159C>T (human)
RGD
PMID:12566518
RGD:7204499
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd163
CD163 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
G
Cd44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
G
Cfb
complement factor B
disease_progression
ISO
mRNA:increased expression:kidney protein:increased expression:serum
RGD
PMID:8567024 PMID:3118258 PMID:17385664
RGD:7242737 , RGD:7242754 , RGD:7242759
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cfhr1
complement factor H-related 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399633
NCBI chr13:51,395,583...51,410,571
Ensembl chr13:51,369,211...51,410,592
G
Chga
chromogranin A
ISO
associated with Hypertension;DNA:polymorphism:promoter:-415T>C (human)
RGD
PMID:20113265
RGD:6906902
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
G
Coro1c
coronin 1C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr12:42,713,024...42,785,179
Ensembl chr12:42,712,991...42,785,179
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
DNA:SNPs: :rs4674257, rs4674259 (human)
RGD
PMID:21214373
RGD:7257677
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Defa5
defensin alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22197929 PMID:25305756
NCBI chr16:70,342,530...70,344,854
Ensembl chr16:70,342,530...70,344,836
G
Fabp1
fatty acid binding protein 1
ISO
protein:increased expression:urine (human)
RGD
PMID:16118482
RGD:1578453
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fas
Fas cell surface death receptor
treatment
IDA
RGD
PMID:29844269
RGD:13792576
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fcar
Fc alpha receptor
ISO
RGD
PMID:22451718 PMID:21985370
RGD:7242063 , RGD:7242167
NCBI chr 1:69,626,458...69,660,558
G
Fcgr3a
Fc gamma receptor 3A
disease_progression
ISO
DNA:polymorphism:exon:p.F176V(human)
RGD
PMID:16221721
RGD:5508463
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
Fn1
fibronectin 1
ISO
protein:increased expression:kidney
RGD
PMID:15925904
RGD:7206844
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Foxm1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Gpr183
G protein-coupled receptor 183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr15:99,037,764...99,050,550
Ensembl chr15:99,036,367...99,050,559
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
protein:increased expression:urine:
RGD
PMID:23135864 PMID:21467131
RGD:7245479 , RGD:7245983
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hpse
heparanase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr14:8,896,593...8,937,011
Ensembl chr14:8,896,593...8,937,010
G
Igf1r
insulin-like growth factor 1 receptor
ISO
DNA: snp::rs2229765
RGD
PMID:21047277
RGD:7242795
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Il18
interleukin 18
ISO
RGD
PMID:22518072
RGD:6893446
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
no_association
ISO
DNA:SNP:promoter:-889C>T (human)
RGD
PMID:21049406
RGD:6907116
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
no_association
ISO
DNA:SNPs: :rs1143627, rs3917356, rs1143633 (human)
RGD
PMID:19280228 PMID:21049406
RGD:6907082 , RGD:6907116
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human) DNA:polymorphisms:intron, 3' utr:IVS1+1890G>T, IVS1+8796A>G, *138C>G (rs928940, rs439154, rs315951) (human) protein:decreased expression:serum, urine (human) rat model treated with human protein response to immunoglobulin therapy mouse model treated with human protein
RGD
PMID:10916103 PMID:19280228 PMID:16209246 PMID:10566895 PMID:10079261 PMID:9844059 PMID:9370186 More...
RGD:6906961 , RGD:6907082 , RGD:6907414 , RGD:6907427 , RGD:6909131 , RGD:6909132 , RGD:6909150
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Itgb1
integrin subunit beta 1
ISO
protein:increased expression:renal glomerulus
RGD
PMID:9355070
RGD:597805933
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Kif15
kinesin family member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Lair1
leukocyte-associated immunoglobulin-like receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 1:70,068,571...70,187,851
Ensembl chr 1:70,157,681...70,185,807
G
Laptm5
lysosomal protein transmembrane 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
G
Lcn2
lipocalin 2
ISO
protein:increased expression:urine:
RGD
PMID:21467131
RGD:7245983
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lhfpl2
LHFPL tetraspan subfamily member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:25,281,901...25,427,950
G
Man2b1
mannosidase, alpha, class 2B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr19:23,055,092...23,074,398
Ensembl chr19:23,055,097...23,074,389
G
Mertk
MER proto-oncogene, tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 3:115,939,351...116,045,141
Ensembl chr 3:115,939,351...116,046,554
G
Mir20a
microRNA 20a
disease_progression
ISO
RGD
PMID:29459010
RGD:25823149
NCBI chr15:92,181,084...92,181,168
Ensembl chr15:92,181,084...92,181,168
G
Mmp14
matrix metallopeptidase 14
IEP
mRNA:increased expression:glomerulus
RGD
PMID:9848780
RGD:2314955
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Ms4a6a
membrane spanning 4-domains A6A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:208,401,466...208,414,758
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
DNA:polymorphism:Cds :2756A>G(human)
RGD
PMID:21737517
RGD:7207085
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
G
Muc20
mucin 20, cell surface associated
disease_progression
ISO
DNA:repeat
RGD
PMID:16508246
RGD:7364789
NCBI chr11:67,987,816...68,001,496
Ensembl chr11:67,987,800...68,001,495
G
Ngf
nerve growth factor
ISO
DNA:SNP: :rs11102930 (human)
RGD
PMID:21178826
RGD:7242801
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Notch2
notch receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32715474
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
G
Otub1
OTU deubiquitinase, ubiquitin aldehyde binding 1
ISO
protein:increased expression:kidney
RGD
PMID:22279542
RGD:7175260
NCBI chr 1:204,387,215...204,395,495
Ensembl chr 1:204,387,215...204,395,483
G
Pde5a
phosphodiesterase 5A
ISO
DNA:SNP: :rs13124532(human)
RGD
PMID:20563733
RGD:7248685
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
G
Pigr
polymeric immunoglobulin receptor
ISO
ClinVar Annotator: match by term: IgA glomerulonephritis
ClinVar
PMID:12740691 PMID:16282702
NCBI chr13:42,298,905...42,326,877
Ensembl chr13:42,298,914...42,326,875
G
Pla2g7
phospholipase A2 group VII
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:12220450
RGD:7257515
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9002298
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Prc1
protein regulator of cytokinesis 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
RT1-Bb
RT1 class II, locus Bb
disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :HLA-DQB1*0301(human)
CTD RGD
PMID:25305756 PMID:7638860
RGD:36174018
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Scgb1a1
secretoglobin family 1A member 1
disease_progression
ISO ISS
OMIM:161950 | OMIM:616818
MouseDO RGD
PMID:11967037
RGD:6903255
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
G
Sele
selectin E
ISO
DNA:SNP:exon:p.H468Y (human) ClinVar Annotator: match by term: IgA nephropathy, susceptibility to
ClinVar RGD
PMID:11828340 PMID:16282702 PMID:11828340
RGD:1625253
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Sell
selectin L
ISO
RGD
PMID:17452405 PMID:11828340
RGD:7175290 , RGD:1625253
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Serpinb7
serpin family B member 7
disease_progression
ISO
DNA:SNPs:3' utr:2093C>T, 2180C>T (human) DNA:SNP: :23167A>G (human) DNA:SNP:5' utr, exon:267G>A (human)
RGD
PMID:18793525 PMID:16550745 PMID:16796905
RGD:7207366 , RGD:7207372 , RGD:7207380
NCBI chr13:23,369,830...23,442,205
Ensembl chr13:23,395,671...23,442,205
G
Shh
sonic hedgehog signaling molecule
ISO
RGD
PMID:24744439
RGD:12859042
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Slc43a3
solute carrier family 43, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr 3:70,008,160...70,030,324
Ensembl chr 3:70,009,313...70,029,749
G
Spry2
sprouty RTK signaling antagonist 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: IgA nephropathy, susceptibility to, 3
OMIM CTD ClinVar
PMID:25741868 PMID:25782674
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
G
St6galnac2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17480010
NCBI chr10:101,910,220...101,928,412
Ensembl chr10:101,909,971...101,915,008 Ensembl chr10:101,909,971...101,915,008
G
Stat4
signal transducer and activator of transcription 4
disease_progression no_association
ISO
DNA:SNP: :rs7561832 (human) DNA:SNP:intron:c.274-28828C>G (rs10181656) (human)
RGD
PMID:20045654 PMID:20479942
RGD:7207872 , RGD:7207878
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11728950
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Timp1
TIMP metallopeptidase inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tlr1
toll-like receptor 1
susceptibility
ISO
DNA:snps:promoter, cds:g.-414C>T, p.N248S (rs5743557, rs4833095) (human)
RGD
PMID:21108742
RGD:7246898
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
G
Tlr9
toll-like receptor 9
severity treatment
ISO
DNA, mRNA:SNP, increased expression:exon, spleen:g.159C>G (mouse) DNA:SNPs:intron, exon:IVS4-44A>G, c.1635G>A (rs352139, rs352140) (human) associated with Graft vs Host Disease associated with Graft vs Host Disease; mRNA:increased expression:splenocyte (mouse)
RGD
PMID:18776126 PMID:18776126 PMID:21621468 PMID:21621468
RGD:7246889 , RGD:7246889 , RGD:7246893 , RGD:7246893
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
treatment
ISO
RGD
PMID:9844059
RGD:6909132
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
ISO
protein:increased expression:serum
RGD
PMID:16209246 PMID:9844059
RGD:6907414 , RGD:6909132
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
treatment
ISO
protein:increased expression:serum
RGD
PMID:16209246 PMID:9844059
RGD:6907414 , RGD:6909132
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfsf13
TNF superfamily member 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22197929
NCBI chr10:54,400,054...54,403,723
Ensembl chr10:54,400,065...54,403,042
G
Tnfsf13b
TNF superfamily member 13b
ISS
OMIM:161950
MouseDO
NCBI chr16:79,462,406...79,492,888
Ensembl chr16:79,462,402...79,492,693
G
Tnfsf14
TNF superfamily member 14
ISS
OMIM:161950
MouseDO
NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216
G
Vav3
vav guanine nucleotide exchange factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25305756
NCBI chr 2:197,011,901...197,354,321
Ensembl chr 2:197,011,831...197,354,321
G
Vsig4
V-set and immunoglobulin domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25133636
NCBI chr X:61,144,926...61,170,212
Ensembl chr X:61,144,928...61,170,212
G
Was
WASP actin nucleation promoting factor
ISS
OMIM:161950 | OMIM:616818
MouseDO
NCBI chr X:14,405,105...14,413,850
Ensembl chr X:14,405,124...14,413,849
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all